PB 60 of 2024
National Health (Price and Special Patient Contribution) Amendment Determination 2024 (No. 5)
I, Nikolai Tsyganov, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination:
Dated 30 May 2024
NIKOLAI TSYGANOV
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
1 Name
This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2024 (No. 5).
This instrument may also be cited as PB 60 of 2024.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information |
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 June 2024 | |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under section 85B of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)
- Schedule 1 – omit entry for Anastrozole
2. Schedule 1 – entry for Codeine with paracetamol
Omit
Codeine with paracetamol | Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg | Oral | Panadeine Forte | 20 | 2.50 | 5.40 |
Insert
Codeine with paracetamol | Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg | Oral | Panadeine Forte | 20 | 2.50 | 5.78 |
3. Schedule 1 – entry for Irbesartan
Omit
Irbesartan | Tablet 75 mg | Oral | Avapro | 30 | 2.50 | 5.40 |
| | | Karvea | 30 | 2.50 | 5.40 |
| Tablet 150 mg | Oral | Avapro | 30 | 2.50 | 5.40 |
| | | Karvea | 30 | 2.50 | 5.40 |
| Tablet 300 mg | Oral | Avapro | 30 | 3.50 | 6.40 |
| | | Karvea | 30 | 3.50 | 6.40 |
Insert
Irbesartan | Tablet 75 mg | Oral | Avapro | 30 | 2.50 | 5.40 |
| | | Karvea | 30 | 2.50 | 5.40 |
| Tablet 150 mg | Oral | Avapro | 30 | 2.50 | 5.78 |
| | | Karvea | 30 | 2.50 | 5.78 |
| Tablet 300 mg | Oral | Avapro | 30 | 3.50 | 6.75 |
| | | Karvea | 30 | 3.50 | 6.75 |
| | | | | | | | | | | |
4. Schedule 1 – entry for Irbesartan with hydrochlorothiazide
Omit
Irbesartan with hydrochlorothiazide | Tablet 150 mg‑12.5 mg | Oral | Avapro HCT 150/12.5 | 30 | 2.50 | 5.40 |
| | | Karvezide 150/12.5 | 30 | 2.50 | 5.40 |
| Tablet 300 mg‑12.5 mg | Oral | Avapro HCT 300/12.5 | 30 | 3.60 | 6.50 |
| | | Karvezide 300/12.5 | 30 | 3.60 | 6.50 |
| Tablet 300 mg‑25 mg | Oral | Avapro HCT 300/25 | 30 | 3.92 | 6.82 |
| | | Karvezide 300/25 | 30 | 3.92 | 6.82 |
Insert
Irbesartan with hydrochlorothiazide | Tablet 150 mg‑12.5 mg | Oral | Avapro HCT 150/12.5 | 30 | 2.50 | 5.78 |
| | | Karvezide 150/12.5 | 30 | 2.50 | 5.78 |
| Tablet 300 mg‑12.5 mg | Oral | Avapro HCT 300/12.5 | 30 | 3.60 | 6.85 |
| | | Karvezide 300/12.5 | 30 | 3.60 | 6.85 |
| Tablet 300 mg‑25 mg | Oral | Avapro HCT 300/25 | 30 | 3.92 | 7.17 |
| | | Karvezide 300/25 | 30 | 3.92 | 7.17 |
5. Schedule 1 – entry for Levonorgestrel with ethinylestradiol
Omit
Levonorgestrel with ethinylestradiol | Pack containing 21 tablets 150 micrograms 30 micrograms and 7 inert tablets | Oral | Levlen ED | 4 | 4.00 | 7.89 |
| | | Triquilar ED | 4 | 7.18 | 19.79 |
Insert
Levonorgestrel with ethinylestradiol | Pack containing 21 tablets 150 micrograms- 30 micrograms and 7 inert tablets | Oral | Levlen ED | 4 | 4.00 | 9.37 |
| Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets | Oral | Triquilar ED | 4 | 7.18 | 19.79 |
6. Schedule 1 – entry for Metronidazole
Omit
Metronidazole | Tablet 400 mg | Oral | Flagyl | 21 | 3.27 | 5.13 |
Insert
Metronidazole | Tablet 400 mg | Oral | Flagyl | 21 | 3.27 | 5.75 |
7. Schedule 1 – entry for Salbutamol
Omit
Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 2.98 | 4.54 |
| Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 3.11 | 4.66 |
| Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth | Asmol CFC-Free with dose counter | 1 | 4.92 | 5.85 |
| Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth | Ventolin CFC-Free with dose counter | 1 | 4.92 | 7.71 |
Insert
Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 2.98 | 4.54 |
| Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 3.11 | 4.66 |
| Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth | Asmol CFC-Free with dose counter | 1 | 5.42 | 5.85 |
| Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth | Ventolin CFC-Free with dose counter | 1 | 5.42 | 7.71 |
8. Schedule 1 – entry for Sumatriptan
Omit
Sumatriptan | Tablet 50 mg (as succinate) | Oral | Imigran | 2 | 2.90 | 4.85 |
| | | | 4 | | 9.70 |
| Tablet (fast disintegrating) 50 mg (as succinate) | Oral | Imigran FDT | 4 | | 9.70 |
Insert
Sumatriptan | Tablet 50 mg (as succinate) | Oral | Imigran | 2 | 2.90 | 4.85 |
| | | | 4 | 2.90 | 9.70 |
| | | Imigran Migraine | 2 | 2.90 | 4.85 |
| Tablet (fast disintegrating) 50 mg (as succinate) | Oral | Imigran FDT | 4 | 5.80 | 9.70 |